β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.6084/m9.figshare.7268435.v2
Complement system and dendritic cells (DCs) form – beside neutrophils and macrophages – the first line of defense to combat fungal infections. Therefore, we here studied interactions of these first immune elements with Aspergillus fumigatus lacking ß-1,3-glucans (fks1tetOnrep under repressed conditions) to mechanistically explain the mode of action of echinocandins in more detail. Echinocandins are cell wall active agents blocking β-glucan synthase, making the A. fumigatus fks1tetOn mutant a good model to study immune-modulatory actions of these drugs. We now demonstrate herein, that complement was activated to significantly higher levels by the fks1-deficient strain compared to its respective wild type. This enhanced covalent linking of complement fragments to the A. fumigatus fks1tetOnrep mutant further resulted in enhanced DC binding and internalization of the fungus. Additionally, we found that fks1tetOnrep induced a Th1-/Th17-polarizing cytokine profile program in DCs. The effect was essentially dependent on massive galactomannan shedding, since blocking of DC-SIGN significantly reduced the fks1tetOnrep-mediated induction of an inflammatory cytokine profile. Our data demonstrate that lack of ß-1,3-glucan, also found under echinocandin therapy, results in improved recognition of Aspergillus fumigatus by complement and DCs and therefore not only directly affects the fungus by its fungistatic actions, but also is likely to exert indirect antifungal mechanisms by strengthening innate host immune mechanisms. Abbreviations: C: complement; CR:complement receptor; DC: dendritic cell; iDC: immature dendritic cell; DC-SIGN: Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin; ERK: extracellular signal–regulated kinases; JNK : c-Jun N-terminal kinases; MAPK: mitogen-activated protein kinase; NHS: normal human serum; PRR: pattern recognition receptor; Th :T helper; TLR :Toll-like receptor; WT: wild type.
Related Topics
- Type
- dataset
- Language
- en
- Landing Page
- https://doi.org/10.6084/m9.figshare.7268435.v2
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394210310
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394210310Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.6084/m9.figshare.7268435.v2Digital Object Identifier
- Title
-
β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cellsWork title
- Type
-
datasetOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-01-01Full publication date if available
- Authors
-
Marion Steger, Marta Bermejo‐Jambrina, Teodor E. Yordanov, Johannes Wagener, Axel A. Brakhage, Verena Pittl, Lukas A. Huber, Hubertus Haas, Cornelia Lass‐Flörl, Wilfried Posch, Doris WilflingsederList of authors in order
- Landing page
-
https://doi.org/10.6084/m9.figshare.7268435.v2Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.6084/m9.figshare.7268435.v2Direct OA link when available
- Concepts
-
Aspergillus fumigatus, Antifungal, Immune system, Microbiology, Complement (music), Glucan, Biology, Immunology, Genetics, Biochemistry, Phenotype, Complementation, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394210310 |
|---|---|
| doi | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| ids.doi | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| ids.openalex | https://openalex.org/W4394210310 |
| fwci | |
| type | dataset |
| title | β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10150 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9879999756813049 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Antifungal resistance and susceptibility |
| topics[1].id | https://openalex.org/T10520 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9516000151634216 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1110 |
| topics[1].subfield.display_name | Plant Science |
| topics[1].display_name | Mycotoxins in Agriculture and Food |
| topics[2].id | https://openalex.org/T10869 |
| topics[2].field.id | https://openalex.org/fields/11 |
| topics[2].field.display_name | Agricultural and Biological Sciences |
| topics[2].score | 0.9269999861717224 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1110 |
| topics[2].subfield.display_name | Plant Science |
| topics[2].display_name | Polysaccharides and Plant Cell Walls |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779787849 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8494687080383301 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q134359 |
| concepts[0].display_name | Aspergillus fumigatus |
| concepts[1].id | https://openalex.org/C2779548794 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6652523279190063 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q578726 |
| concepts[1].display_name | Antifungal |
| concepts[2].id | https://openalex.org/C8891405 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6324520111083984 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[2].display_name | Immune system |
| concepts[3].id | https://openalex.org/C89423630 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5898661017417908 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[3].display_name | Microbiology |
| concepts[4].id | https://openalex.org/C112313634 |
| concepts[4].level | 5 |
| concepts[4].score | 0.5829532146453857 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7886648 |
| concepts[4].display_name | Complement (music) |
| concepts[5].id | https://openalex.org/C2776123893 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5383234024047852 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q416796 |
| concepts[5].display_name | Glucan |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.4763607978820801 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C203014093 |
| concepts[7].level | 1 |
| concepts[7].score | 0.36160361766815186 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[7].display_name | Immunology |
| concepts[8].id | https://openalex.org/C54355233 |
| concepts[8].level | 1 |
| concepts[8].score | 0.04465663433074951 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[8].display_name | Genetics |
| concepts[9].id | https://openalex.org/C55493867 |
| concepts[9].level | 1 |
| concepts[9].score | 0.04355999827384949 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[9].display_name | Biochemistry |
| concepts[10].id | https://openalex.org/C127716648 |
| concepts[10].level | 3 |
| concepts[10].score | 0.04287707805633545 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q104053 |
| concepts[10].display_name | Phenotype |
| concepts[11].id | https://openalex.org/C188082640 |
| concepts[11].level | 4 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1780899 |
| concepts[11].display_name | Complementation |
| concepts[12].id | https://openalex.org/C104317684 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[12].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/aspergillus-fumigatus |
| keywords[0].score | 0.8494687080383301 |
| keywords[0].display_name | Aspergillus fumigatus |
| keywords[1].id | https://openalex.org/keywords/antifungal |
| keywords[1].score | 0.6652523279190063 |
| keywords[1].display_name | Antifungal |
| keywords[2].id | https://openalex.org/keywords/immune-system |
| keywords[2].score | 0.6324520111083984 |
| keywords[2].display_name | Immune system |
| keywords[3].id | https://openalex.org/keywords/microbiology |
| keywords[3].score | 0.5898661017417908 |
| keywords[3].display_name | Microbiology |
| keywords[4].id | https://openalex.org/keywords/complement |
| keywords[4].score | 0.5829532146453857 |
| keywords[4].display_name | Complement (music) |
| keywords[5].id | https://openalex.org/keywords/glucan |
| keywords[5].score | 0.5383234024047852 |
| keywords[5].display_name | Glucan |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.4763607978820801 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/immunology |
| keywords[7].score | 0.36160361766815186 |
| keywords[7].display_name | Immunology |
| keywords[8].id | https://openalex.org/keywords/genetics |
| keywords[8].score | 0.04465663433074951 |
| keywords[8].display_name | Genetics |
| keywords[9].id | https://openalex.org/keywords/biochemistry |
| keywords[9].score | 0.04355999827384949 |
| keywords[9].display_name | Biochemistry |
| keywords[10].id | https://openalex.org/keywords/phenotype |
| keywords[10].score | 0.04287707805633545 |
| keywords[10].display_name | Phenotype |
| language | en |
| locations[0].id | doi:10.6084/m9.figshare.7268435.v2 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | dataset |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| indexed_in | datacite |
| authorships[0].author.id | https://openalex.org/A5013842588 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Marion Steger |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Marion Steger |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5037856313 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-1931-6913 |
| authorships[1].author.display_name | Marta Bermejo‐Jambrina |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Marta Bermejo-Jambrina |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5079065523 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4801-0673 |
| authorships[2].author.display_name | Teodor E. Yordanov |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Teodor Yordanov |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5000829320 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5952-9422 |
| authorships[3].author.display_name | Johannes Wagener |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Johannes Wagener |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5054532448 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8814-4193 |
| authorships[4].author.display_name | Axel A. Brakhage |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Axel A Brakhage |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5001034717 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Verena Pittl |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Verena Pittl |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5034693291 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1116-2120 |
| authorships[6].author.display_name | Lukas A. Huber |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Lukas A Huber |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5060027924 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2472-9878 |
| authorships[7].author.display_name | Hubertus Haas |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Hubertus Haas |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5064996258 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-2946-7785 |
| authorships[8].author.display_name | Cornelia Lass‐Flörl |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Cornelia Lass-Flörl |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5086828978 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-8955-7654 |
| authorships[9].author.display_name | Wilfried Posch |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Wilfried Posch |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5056858893 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-5888-5118 |
| authorships[10].author.display_name | Doris Wilflingseder |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Doris Wilflingseder |
| authorships[10].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T06:51:31.235846 |
| primary_topic.id | https://openalex.org/T10150 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9879999756813049 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Antifungal resistance and susceptibility |
| related_works | https://openalex.org/W4231480692, https://openalex.org/W4300116218, https://openalex.org/W2328163262, https://openalex.org/W2047027128, https://openalex.org/W1966314028, https://openalex.org/W2559575971, https://openalex.org/W4386021408, https://openalex.org/W4313137196, https://openalex.org/W235021904, https://openalex.org/W2888003270 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.6084/m9.figshare.7268435.v2 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | dataset |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| primary_location.id | doi:10.6084/m9.figshare.7268435.v2 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | dataset |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.6084/m9.figshare.7268435.v2 |
| publication_date | 2018-01-01 |
| publication_year | 2018 |
| referenced_works_count | 0 |
| abstract_inverted_index.: | 234 |
| abstract_inverted_index.a | 68, 130 |
| abstract_inverted_index.:T | 251 |
| abstract_inverted_index.C: | 211 |
| abstract_inverted_index.DC | 117 |
| abstract_inverted_index.Th | 250 |
| abstract_inverted_index.We | 78 |
| abstract_inverted_index.an | 156 |
| abstract_inverted_index.by | 90, 179, 191, 204 |
| abstract_inverted_index.in | 50, 115, 135, 173 |
| abstract_inverted_index.is | 197 |
| abstract_inverted_index.of | 16, 27, 46, 48, 75, 104, 121, 148, 155, 165, 176 |
| abstract_inverted_index.on | 142 |
| abstract_inverted_index.to | 18, 41, 71, 86, 95, 107, 199 |
| abstract_inverted_index.we | 23, 125 |
| abstract_inverted_index.DC: | 215 |
| abstract_inverted_index.DCs | 182 |
| abstract_inverted_index.JNK | 233 |
| abstract_inverted_index.Our | 160 |
| abstract_inverted_index.TLR | 253 |
| abstract_inverted_index.The | 137 |
| abstract_inverted_index.WT: | 256 |
| abstract_inverted_index.and | 2, 10, 119, 181, 183 |
| abstract_inverted_index.are | 54 |
| abstract_inverted_index.but | 195 |
| abstract_inverted_index.its | 96, 192 |
| abstract_inverted_index.not | 185 |
| abstract_inverted_index.now | 79 |
| abstract_inverted_index.the | 13, 44, 63, 91, 108, 122, 152, 189 |
| abstract_inverted_index.was | 84, 139 |
| abstract_inverted_index.– | 7, 12 |
| abstract_inverted_index.DCs. | 136 |
| abstract_inverted_index.ERK: | 229 |
| abstract_inverted_index.NHS: | 242 |
| abstract_inverted_index.PRR: | 246 |
| abstract_inverted_index.This | 100 |
| abstract_inverted_index.also | 167, 196 |
| abstract_inverted_index.cell | 55 |
| abstract_inverted_index.data | 161 |
| abstract_inverted_index.form | 6 |
| abstract_inverted_index.good | 69 |
| abstract_inverted_index.here | 24 |
| abstract_inverted_index.host | 207 |
| abstract_inverted_index.iDC: | 218 |
| abstract_inverted_index.lack | 164 |
| abstract_inverted_index.line | 15 |
| abstract_inverted_index.mode | 45 |
| abstract_inverted_index.more | 51 |
| abstract_inverted_index.only | 186 |
| abstract_inverted_index.that | 82, 127, 163 |
| abstract_inverted_index.wall | 56 |
| abstract_inverted_index.wild | 98, 257 |
| abstract_inverted_index.with | 32 |
| abstract_inverted_index.(DCs) | 5 |
| abstract_inverted_index.<i>A. | 64, 109 |
| abstract_inverted_index.MAPK: | 238 |
| abstract_inverted_index.c-Jun | 235 |
| abstract_inverted_index.cell; | 217, 221 |
| abstract_inverted_index.cells | 4 |
| abstract_inverted_index.exert | 200 |
| abstract_inverted_index.first | 14, 29 |
| abstract_inverted_index.found | 126, 168 |
| abstract_inverted_index.human | 244 |
| abstract_inverted_index.model | 70 |
| abstract_inverted_index.since | 146 |
| abstract_inverted_index.study | 72 |
| abstract_inverted_index.these | 28, 76 |
| abstract_inverted_index.type. | 99, 258 |
| abstract_inverted_index.under | 38, 169 |
| abstract_inverted_index.action | 47 |
| abstract_inverted_index.active | 57 |
| abstract_inverted_index.agents | 58 |
| abstract_inverted_index.beside | 8 |
| abstract_inverted_index.combat | 19 |
| abstract_inverted_index.drugs. | 77 |
| abstract_inverted_index.effect | 138 |
| abstract_inverted_index.fungal | 20 |
| abstract_inverted_index.fungus | 190 |
| abstract_inverted_index.higher | 88 |
| abstract_inverted_index.immune | 30, 208 |
| abstract_inverted_index.innate | 206 |
| abstract_inverted_index.levels | 89 |
| abstract_inverted_index.likely | 198 |
| abstract_inverted_index.making | 62 |
| abstract_inverted_index.mutant | 67, 112 |
| abstract_inverted_index.normal | 243 |
| abstract_inverted_index.serum; | 245 |
| abstract_inverted_index.strain | 93 |
| abstract_inverted_index.system | 1 |
| abstract_inverted_index.DC-SIGN | 149 |
| abstract_inverted_index.actions | 74 |
| abstract_inverted_index.affects | 188 |
| abstract_inverted_index.binding | 118 |
| abstract_inverted_index.defense | 17 |
| abstract_inverted_index.detail. | 52 |
| abstract_inverted_index.explain | 43 |
| abstract_inverted_index.fungus. | 123 |
| abstract_inverted_index.further | 113 |
| abstract_inverted_index.helper; | 252 |
| abstract_inverted_index.herein, | 81 |
| abstract_inverted_index.induced | 129 |
| abstract_inverted_index.kinase; | 241 |
| abstract_inverted_index.lacking | 35 |
| abstract_inverted_index.linking | 103 |
| abstract_inverted_index.massive | 143 |
| abstract_inverted_index.pattern | 247 |
| abstract_inverted_index.profile | 133 |
| abstract_inverted_index.program | 134 |
| abstract_inverted_index.protein | 240 |
| abstract_inverted_index.reduced | 151 |
| abstract_inverted_index.results | 172 |
| abstract_inverted_index.studied | 25 |
| abstract_inverted_index.DC-SIGN: | 222 |
| abstract_inverted_index.actions, | 194 |
| abstract_inverted_index.adhesion | 226 |
| abstract_inverted_index.blocking | 59, 147 |
| abstract_inverted_index.compared | 94 |
| abstract_inverted_index.covalent | 102 |
| abstract_inverted_index.cytokine | 132, 158 |
| abstract_inverted_index.directly | 187 |
| abstract_inverted_index.elements | 31 |
| abstract_inverted_index.enhanced | 101, 116 |
| abstract_inverted_index.immature | 219 |
| abstract_inverted_index.improved | 174 |
| abstract_inverted_index.indirect | 201 |
| abstract_inverted_index.kinases; | 232, 237 |
| abstract_inverted_index.profile. | 159 |
| abstract_inverted_index.resulted | 114 |
| abstract_inverted_index.therapy, | 171 |
| abstract_inverted_index.Dendritic | 223 |
| abstract_inverted_index.activated | 85 |
| abstract_inverted_index.dendritic | 3, 216, 220 |
| abstract_inverted_index.dependent | 141 |
| abstract_inverted_index.fragments | 106 |
| abstract_inverted_index.fumigatus | 65, 110 |
| abstract_inverted_index.induction | 154 |
| abstract_inverted_index.receptor; | 214, 249, 255 |
| abstract_inverted_index.repressed | 39 |
| abstract_inverted_index.shedding, | 145 |
| abstract_inverted_index.synthase, | 61 |
| abstract_inverted_index.therefore | 184 |
| abstract_inverted_index.β-glucan | 60 |
| abstract_inverted_index.:Toll-like | 254 |
| abstract_inverted_index.Complement | 0 |
| abstract_inverted_index.N-terminal | 236 |
| abstract_inverted_index.Therefore, | 22 |
| abstract_inverted_index.antifungal | 202 |
| abstract_inverted_index.complement | 83, 105, 180 |
| abstract_inverted_index.mechanisms | 203 |
| abstract_inverted_index.respective | 97 |
| abstract_inverted_index.complement; | 212 |
| abstract_inverted_index.conditions) | 40 |
| abstract_inverted_index.demonstrate | 80, 162 |
| abstract_inverted_index.essentially | 140 |
| abstract_inverted_index.fungistatic | 193 |
| abstract_inverted_index.infections. | 21 |
| abstract_inverted_index.macrophages | 11 |
| abstract_inverted_index.mechanisms. | 209 |
| abstract_inverted_index.neutrophils | 9 |
| abstract_inverted_index.recognition | 175, 248 |
| abstract_inverted_index.echinocandin | 170 |
| abstract_inverted_index.inflammatory | 157 |
| abstract_inverted_index.interactions | 26 |
| abstract_inverted_index.Additionally, | 124 |
| abstract_inverted_index.CR:complement | 213 |
| abstract_inverted_index.Cell-Specific | 224 |
| abstract_inverted_index.Echinocandins | 53 |
| abstract_inverted_index.Intercellular | 225 |
| abstract_inverted_index.Non-integrin; | 228 |
| abstract_inverted_index.echinocandins | 49 |
| abstract_inverted_index.extracellular | 230 |
| abstract_inverted_index.fumigatus</i> | 34, 178 |
| abstract_inverted_index.galactomannan | 144 |
| abstract_inverted_index.significantly | 87, 150 |
| abstract_inverted_index.strengthening | 205 |
| abstract_inverted_index.<i>Aspergillus | 33, 177 |
| abstract_inverted_index.ß-1,3-glucan, | 166 |
| abstract_inverted_index.ß-1,3-glucans | 36 |
| abstract_inverted_index.internalization | 120 |
| abstract_inverted_index.mechanistically | 42 |
| abstract_inverted_index.immune-modulatory | 73 |
| abstract_inverted_index.mitogen-activated | 239 |
| abstract_inverted_index.signal–regulated | 231 |
| abstract_inverted_index.molecule-3-Grabbing | 227 |
| abstract_inverted_index.Th1-/Th17-polarizing | 131 |
| abstract_inverted_index.<b>Abbreviations</b>: | 210 |
| abstract_inverted_index.<i>fks1-</i>deficient | 92 |
| abstract_inverted_index.fks1<sub>tetOn</sub></i> | 66 |
| abstract_inverted_index.fks1<sub>tetOn</sub><sup>rep</sup></i> | 111 |
| abstract_inverted_index.<i>fks1<sub>tetOn</sub><sup>rep</sup></i> | 128 |
| abstract_inverted_index.(<i>fks1<sub>tetOn</sub><sup>rep</sup></i> | 37 |
| abstract_inverted_index.<i>fks1<sub>tetOn</sub><sup>rep</sup>-</i>mediated | 153 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 11 |
| citation_normalized_percentile |